Larvol Delta - Safety-and-feasibility-of-an-in-situ-vaccination-and-immunomodulatory-targeted-radionuclide-combination-immunoradiotherapy-approach-in-a-comparative-companion-dog-setting

lorukafusp alfa (APN301) - Apeiron Biologics

90Y-NM600 - Archeus Technologies

http://www.ncbi.nlm.nih.gov/pubmed/34383787

Aug 13, 2021

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next